Timothy Marlowe

Education

• Postdoctoral Fellowship: University of Arizona, 2017
• PhD: Molecular Pharmacology & Cancer Therapeutics, Roswell Park Cancer Institute, 2016

Publications

• Stahl E, Nott R, Koessel K, Cance W & Marlowe T (2020). Computational-based discovery of FAK FERM domain chemical probes that inhibit HER2-FAK cancer signaling. Chemical Biology & Drug Design., 02/20/2020 - Article, Refereed Journal -
• Alvarado C, Stahl E, Koessel K, Rivera A, Cherry B, Pulavarti SV, Szyperski T, Cance WG & Marlowe T (2019). Development of a fragment-based screening assay for the focal adhesion targeting domain using SPR and NMR. Molecules. Molecules. Vol. 24(18), 09/14/2019 - Article, Refereed Journal -
• Marlowe T, Alvarado C, Rivera A, Lenzo F, Nott R, Bondugji D, Montoya J, Hurley A, Kaplan M, Capaldi A & Cance WG (2019). Development of a high-throughput fluorescence polarization assay to detect inhibitors of FAK-Paxillin binding. SLAS Discovery., 09/12/2019 - Article, Refereed Journal -
• Marlowe T, Lenzo F, Figel S, Grapes A & Cance WG (2016). Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors. Molecular Cancer Therapeutics., 12/2016 - Article, Refereed Journal -
• Cance WG, Kurenova E, Marlowe T & Golubovskaya V (2013). Disrupting the Scaffold to Improve Focal Adhesion Kinase-Targeted Cancer Therapeutics. Science Signaling., 03/26/2013 - Article, Refereed Journal -